Market Research Report - 194077
Triple Analysis: Leukemia, Cancer Vaccines and Protein Kinase Inhibitors
|Published by||BioSeeker Group AB|
|Published||Content info||5094 Pages|
|Triple Analysis: Leukemia, Cancer Vaccines and Protein Kinase Inhibitors|
|Published: March 19, 2013||Content info: 5094 Pages||
This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas.
This Report Includes the Following Companies: